Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

SULTAMICILLIN CRS (10 MG)

SULTAMICILLIN CRS (10 MG)

76497-13-7

DISCOVER
SULTAMICILLIN TOSILATE CRS (200 MG)

SULTAMICILLIN TOSILATE CRS (200 MG)

83105-70-8

DISCOVER
SULTAMICILLIN FOR PEAK IDENTIFICATION CRS (10 MG)

SULTAMICILLIN FOR PEAK IDENTIFICATION CRS (10 MG)

76497-13-7

DISCOVER
VALNEMULIN HYDROGEN TARTRATE CRS (120 MG)

VALNEMULIN HYDROGEN TARTRATE CRS (120 MG)

NA

DISCOVER
ZUCLOPENTHIXOL FOR SYSTEM SUITABILITY CRS (0.26 MG)

ZUCLOPENTHIXOL FOR SYSTEM SUITABILITY CRS (0.26 MG)

NA

DISCOVER
TERBINAFINE HYDROCHLORIDE CRS(15 MG)

TERBINAFINE HYDROCHLORIDE CRS(15 MG)

78628-80-5

DISCOVER
CARBOPROST TROMETAMOL - REFERENCE SPECTRUM (N/A)

CARBOPROST TROMETAMOL - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
EMEDASTINE DIFUMARATE CRS (10MG)

EMEDASTINE DIFUMARATE CRS (10MG)

87233-62-3

DISCOVER
DEXAMETHASONE ISONICOTINATE CRS (10 MG)

DEXAMETHASONE ISONICOTINATE CRS (10 MG)

2265-64-7

DISCOVER
IMMUNOGLOBULIN PANEL FOR ANTI-D ANTIBODIES TEST BRP (2000 MG

IMMUNOGLOBULIN PANEL FOR ANTI-D ANTIBODIES TEST BRP (2000 MG

9007-83-4

DISCOVER
THIORIDAZINE FOR SYSTEM SUITABILITY CRS (0.21 MG)

THIORIDAZINE FOR SYSTEM SUITABILITY CRS (0.21 MG)

50-52-2

DISCOVER
NANDROLONE DECANOATE CRS (5 MG)

NANDROLONE DECANOATE CRS (5 MG)

360-70-3

DISCOVER